Premium
FUNCTIONAL INTERACTION BETWEEN DPI 201‐106, A DRUG THAT MIMICS CONGENITAL LONG QT SYNDROME, AND SEVOFLURANE ON THE GUINEA‐PIG CARDIAC ACTION POTENTIAL
Author(s) -
Kang Jiesheng,
Chen XiaoLiang,
Reynolds William P,
Rampe David
Publication year - 2007
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.2007.04805.x
Subject(s) - sevoflurane , long qt syndrome , medicine , qt interval , anesthesia , pharmacology , cardiac action potential , electrophysiology , cardiology , repolarization
SUMMARY1 Sevoflurane produces QT prolongation on the electrocardiogram, predominantly via inhibition of the slow delayed rectifier K + current. DPI 201‐106 is an experimental drug that produces QT prolongation by reducing Na + channel inactivation, thereby mimicking congenital long QT syndrome type 3 (LQT3). The present study explores the electrophysiological consequences of administration of sevoflurane in the presence of impaired Na + channel activity. 2 We examined the effects of sevoflurane and DPI 201‐106, alone and in combination, on the cardiac action potential of guinea‐pig ventricular myocytes using standard microelectrode techniques. 3 Both sevoflurane and DPI‐201‐106 prolonged action potential duration, with the combination of the two drugs producing greater than additive effects. Similarly, instability and triangulation of the action potential waveform, measures of pro‐arrhythmia, were more pronounced when both drugs were combined. 4 Sevoflurane treatment significantly alters cardiac action potential waveforms when administered in the presence of impaired Na + channel inactivation. These results indicate the potential for ventricular arrhythmia when sevoflurane is administered to LQT3 patients and suggests caution when using sevoflurane in this population.